New drug aims to help breathing in severe lung failure
NCT ID NCT05938036
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tests a new medicine called ALT-100 in people with moderate to severe acute respiratory distress syndrome (ARDS), a serious lung condition that makes breathing very hard. The trial involves 15 adults who receive a single dose of the drug or a placebo to see if it is safe and helps reduce the need for a breathing machine. The goal is to improve recovery and shorten hospital stays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banner University of Arizona
Tucson, Arizona, 85721, United States
Conditions
Explore the condition pages connected to this study.